View Item 

Show simple item record

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

dc.contributor.authorRunowicz, Carolyn D.
dc.contributor.authorLeach, Corinne R.
dc.contributor.authorHenry, N. Lynn
dc.contributor.authorHenry, Karen S.
dc.contributor.authorMackey, Heather T.
dc.contributor.authorCowens‐alvarado, Rebecca L.
dc.contributor.authorCannady, Rachel S.
dc.contributor.authorPratt‐chapman, Mandi L.
dc.contributor.authorEdge, Stephen B.
dc.contributor.authorJacobs, Linda A.
dc.contributor.authorHurria, Arti
dc.contributor.authorMarks, Lawrence B.
dc.contributor.authorLaMonte, Samuel J.
dc.contributor.authorWarner, Ellen
dc.contributor.authorLyman, Gary H.
dc.contributor.authorGanz, Patricia A.
dc.date.accessioned2017-04-14T15:11:38Z
dc.date.available2017-04-14T15:11:38Z
dc.date.issued2016-01
dc.identifier.citationRunowicz, Carolyn D.; Leach, Corinne R.; Henry, N. Lynn; Henry, Karen S.; Mackey, Heather T.; Cowens‐alvarado, Rebecca L. ; Cannady, Rachel S.; Pratt‐chapman, Mandi L. ; Edge, Stephen B.; Jacobs, Linda A.; Hurria, Arti; Marks, Lawrence B.; LaMonte, Samuel J.; Warner, Ellen; Lyman, Gary H.; Ganz, Patricia A. (2016). "American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline." CA: A Cancer Journal for Clinicians 66(1): 43-73.
dc.identifier.issn0007-9235
dc.identifier.issn1542-4863
dc.identifier.urihttps://hdl.handle.net/2027.42/136493
dc.publisherWiley Periodicals, Inc.
dc.publisherAgency for Healthcare Research and Quality
dc.subject.otherprimary care
dc.subject.otherquality of life
dc.subject.othersurvivorship care plan
dc.subject.otherlongâ term effects
dc.subject.otherlate effects
dc.subject.othercare coordination
dc.subject.otherbreast cancer
dc.subject.othersurvivorship
dc.subject.otherclinical care
dc.subject.otherfollowâ up
dc.subject.otherguideline
dc.titleAmerican Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelHematology and Oncology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/136493/1/caac21319_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/136493/2/caac21319-sup-0001-suppinfo1.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/136493/3/caac21319.pdf
dc.identifier.doi10.3322/caac.21319
dc.identifier.sourceCA: A Cancer Journal for Clinicians
dc.identifier.citedreferenceProtani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and metaâ analysis. Breast Cancer Res Treat. 2010; 123: 627 â 635.
dc.identifier.citedreferenceDemarkâ Wahnefried W, Rogers LQ, Alfano CM, et al. Practical clinical interventions for diet, physical activity, and weight control in cancer survivors. CA Cancer J Clin. 2015; 65: 167 â 189.
dc.identifier.citedreferenceLigibel JA, Alfano CM, Courneya KS, et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014; 32: 3568 â 3574.
dc.identifier.citedreferenceUS Preventive Services Task Force. Obesity in Adults: Screening and Management, June 2012. uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/obesityâ inâ adultsâ screeningâ andâ management#references. Accessed August 17, 2015.
dc.identifier.citedreferenceUnderwood JM, Townsend JS, Stewart SL, et al. Surveillance of demographic characteristics and health behaviors among adult cancer survivorsâ Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ. 2012; 61: 1 â 23.
dc.identifier.citedreferenceSchmid D, Leitzmann MF. Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and metaâ analysis. Ann Oncol. 2014; 25: 1293 â 1311.
dc.identifier.citedreferenceZhao G, Li C, Okoro CA, et al. Trends in modifiable lifestyleâ related risk factors following diagnosis in breast cancer survivors. J Cancer Surviv. 2013; 7: 563 â 569.
dc.identifier.citedreferenceBlanchard CM, Courneya KS, Stein K. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with healthâ related quality of life: results from the American Cancer Society’s SCSâ II. J Clin Oncol. 2008; 26: 2198 â 2204.
dc.identifier.citedreferenceForbes CC, Blanchard CM, Mummery WK, Courneya K. Prevalence and correlates of strength exercise among breast, prostate, and colorectal cancer survivors. Oncol Nurs Forum. 2015; 42: 118 â 127.
dc.identifier.citedreferenceIrwin ML, McTiernan A, Manson JE, et al. Physical activity and survival in postmenopausal women with breast cancer: results from the Women’s Health Initiative. Cancer Prev Res (Phila). 2011; 4: 522 â 529.
dc.identifier.citedreferenceKroenke CH, Fung TT, Hu FB, Holmes MD. Dietary patterns and survival after breast cancer diagnosis. J Clin Oncol. 2005; 23: 9295 â 9303.
dc.identifier.citedreferenceKwan ML, Weltzien E, Kushi LH, Castillo A, Slattery ML, Caan BJ. Dietary patterns and breast cancer recurrence and survival among women with earlyâ stage breast cancer. J Clin Oncol. 2009; 27: 919 â 926.
dc.identifier.citedreferenceVrieling A, Buck K, Seibold P, et al. Dietary patterns and survival in German postmenopausal breast cancer survivors. Br J Cancer. 2013; 108: 188 â 192.
dc.identifier.citedreferenceChlebowski RT, Blackburn GL, Thomson CA, et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women’s Intervention Nutrition Study. J Natl Cancer Inst. 2006; 98: 1767 â 1776.
dc.identifier.citedreferencePierce JP, Natarajan L, Caan BJ, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women’s Healthy Eating and Living (WHEL) randomized trial. JAMA. 2007; 298: 289 â 298.
dc.identifier.citedreferenceAmerican Cancer Society. Alcohol Use and Cancer. cancer.org/cancer/cancercauses/dietandphysicalactivity/alcoholâ useâ andâ cancer. Accessed January 6, 2015.
dc.identifier.citedreferenceMcGuire S. US Department of Agriculture and US Department of Health and Human Services, Dietary Guidelines for Americans, 2010. 7th edition, Washington, DC: US Government Printing Office, January 2011. Adv Nutr. 2011; 2: 293 â 294.
dc.identifier.citedreferenceKwan ML, Kushi LH, Weltzien E, et al. Alcohol consumption and breast cancer recurrence and survival among women with earlyâ stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010; 28: 4410 â 4416.
dc.identifier.citedreferenceBaan R, Straif K, Grosse Y, et al. Carcinogenicity of alcoholic beverages. Lancet Oncol. 2007; 8: 292 â 293.
dc.identifier.citedreferenceNelson DE, Jarman DW, Rehm J, et al. Alcoholâ attributable cancer deaths and years of potential life lost in the United States. Am J Public Health. 2013; 103: 641 â 648.
dc.identifier.citedreferenceScoccianti C, Laubyâ Secretan B, Bello PY, Chajes V, Romieu I. Female breast cancer and alcohol consumption: a review of the literature. Am J Prev Med. 2014; 46 ( 3 suppl 1 ): S16 â S25.
dc.identifier.citedreferenceTerry MB, Zhang FF, Kabat G, et al. Lifetime alcohol intake and breast cancer risk. Ann Epidemiol. 2006; 16: 230 â 240.
dc.identifier.citedreferenceBerube S, Lemieux J, Moore L, Maunsell E, Brisson J. Smoking at time of diagnosis and breast cancerâ specific survival: new findings and systematic review with metaâ analysis [serial online]. Breast Cancer Res. 2014; 16: R42.
dc.identifier.citedreferenceNayan S, Gupta MK, Strychowsky JE, Sommer DD. Smoking cessation interventions and cessation rates in the oncology population: an updated systematic review and metaâ analysis. Otolaryngol Head Neck Surg. 2013; 149: 200 â 211.
dc.identifier.citedreferenceBoekhout AH, Maunsell E, Pond GR, et al. A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial [published online ahead of print April 21, 2015 ]. J Cancer Surviv. doi: 10.1007/s11764-015-0443-1.
dc.identifier.citedreferenceMao JJ, Bowman MA, Stricker CT, et al. Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol. 2009; 27: 933 â 938.
dc.identifier.citedreferenceShulman LN, Jacobs LA, Greenfield S, et al. Cancer care and cancer survivorship care in the United States: will we be able to care for these patients in the future? J Oncol Pract. 2009; 5: 119 â 123.
dc.identifier.citedreferenceTravis LB, Yahalom J. Cancer Survivorship. Preface. Hematol Oncol Clin North Am. 2008; 22: xi â xii.
dc.identifier.citedreferenceChildren’s Oncology Group. Longâ Term Followâ Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. survivorshipguidelines.org. Accessed May 15, 2015.
dc.identifier.citedreferenceGrunfeld E, Levine MN, Julian JA, et al. Randomized trial of longâ term followâ up for earlyâ stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006; 24: 848 â 855.
dc.identifier.citedreferenceGrunfeld E, Fitzpatrick R, Mant D, et al. Comparison of breast cancer patient satisfaction with followâ up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract. 1999; 49: 705 â 710.
dc.identifier.citedreferenceDawes AJ, Hemmelgarn M, Nguyen DK, et al. Are primary care providers prepared to care for survivors of breast cancer in the safety net? Cancer. 2015; 121: 1249 â 1256.
dc.identifier.citedreferencePalmer SC, Stricker CT, Panzer SL, et al. Outcomes and satisfaction after delivery of a breast cancer survivorship care plan: results of a multicenter trial [serial online]. J Oncol Pract. 2015; 11: e222 â e229.
dc.identifier.citedreferenceKim Y, Kashy DA, Spillers RL, Evans TV. Needs assessment of family caregivers of cancer survivors: three cohorts comparison. Psychooncology. 2010; 19: 573 â 582.
dc.identifier.citedreferenceKim Y, Spillers RL, Hall DL. Quality of life of family caregivers 5 years after a relative’s cancer diagnosis: followâ up of the national quality of life survey for caregivers. Psychooncology. 2012; 21: 273 â 281.
dc.identifier.citedreferenceGiven BA, Given CW, Sherwood PR. Family and caregiver needs over the course of the cancer trajectory. J Support Oncol. 2012; 10: 57 â 64.
dc.identifier.citedreferenceNational Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. United States Cancer Statistics: 1999â 2011 Incidence and Mortality [webâ based report]. nccd.cdc.gov/uscs/. Accessed April 1, 2015.
dc.identifier.citedreferenceAmerican Cancer Society. Cancer Facts & Figures for African Americans 2013â 2014. Atlanta, GA: American Cancer Society; 2013.
dc.identifier.citedreferenceNational Cancer Institute; Surveillance, Epidemiology, and End Results (SEER) Program. SEER Cancer Statistics Review, 1975â 2011. seer.cancer.gov/archive/csr/1975_2011/. Accessed April 1, 2015.
dc.identifier.citedreferenceMead H, Cartwrightâ Smith L, Jones K, Ramos C, Woods K, Siegel B. Racial and Ethnic Disparities in US Health Care: A Chartbook. New York, NY: The Commonwealth Fund; 2008.
dc.identifier.citedreferenceAmerican Geriatrics Society Expert Panel on the Care of Older Adults With Multimorbidity. Patientâ centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: J Am Geriatr Soc. 2012; 60: 1957 â 1968.
dc.identifier.citedreferenceDeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014; 64: 252 â 271.
dc.identifier.citedreferenceHowlader N, Noone AM, Krapcho M, et al. eds. SEER Cancer Statistics Review, 1975â 2012 [ seer.cancer.gov/csr.1975_2012/, based on the November 2014 SEER data submission, posted to the SEER website April 2015]. Bethesda, MD: National Cancer Institute; 2015.
dc.identifier.citedreferenceGanz PA. Survivorship: adult cancer survivors. Prim Care. 2009; 36: 721 â 741.
dc.identifier.citedreferenceInstitute of Medicine and National Research Council of the National Academies. From Cancer Patient to Cancer Survivor: Lost in Transition. Committee on Cancer Survivorship: Improving Care and Quality of Life, National Cancer Policy Board. Washington, DC: The National Academies Press; 2005.
dc.identifier.citedreferenceInstitute of Medicine (US) Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Washington, DC: The National Academies Press; 2008.
dc.identifier.citedreferenceEarle CC, Ganz PA. Cancer survivorship care: don’t let the perfect be the enemy of the good. J Clin Oncol. 2012; 30: 3764 â 3768.
dc.identifier.citedreferenceGanz PA, Earle CC, Goodwin PJ. J Clin Oncol update on progress in cancer survivorship care and research. J Clin Oncol. 2012; 30: 3655 â 3656.
dc.identifier.citedreferenceCowensâ Alvarado R, Sharpe K, Prattâ Chapman M, et al. Advancing survivorship care through the National Cancer Survivorship Resource Center: developing American Cancer Society guidelines for primary care providers. CA Cancer J Clin. 2013; 63: 147 â 150.
dc.identifier.citedreferenceGradishar WJ, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ® ) Breast Cancer Version 2.2015. © 2015 National Comprehensive Cancer Network, Inc. NCCN.org. Accessed April 1, 2015.
dc.identifier.citedreferenceDenlinger CS, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ® ) Survivorship Version 1.2015. © 2015 National Comprehensive Cancer Network, Inc. NCCN.org. Accessed April 1, 2015.
dc.identifier.citedreferenceKhatcheressian JL, Hurley P, Bantug E, et al. Breast cancer followâ up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013; 31: 961 â 965.
dc.identifier.citedreferenceAmerican Society of Clinical Oncology (ASCO). Cancer Survivorship. asco.org/practiceâ research/cancerâ survivorship. Accessed May 15, 2015.
dc.identifier.citedreferenceBower JE. Cancerâ related fatigueâ mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014; 11: 597 â 609.
dc.identifier.citedreferenceHershman DL, Lacchetti C, Dworkin RH, et al. Prevention and management of chemotherapyâ induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014; 32: 1941 â 1967.
dc.identifier.citedreferenceAndersen BL, DeRubeis RJ, Berman BS, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014; 32: 1605 â 1619.
dc.identifier.citedreferenceSkolarus TA, Wolf AM, Erb NL, et al. American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin. 2014; 64: 225 â 249.
dc.identifier.citedreferenceSiegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65: 5 â 29.
dc.identifier.citedreferenceJatoi I. Options in breast cancer local therapy: who gets what? World J Surg. 2012; 36: 1498 â 1502.
dc.identifier.citedreferenceJatoi I, Proschan MA. Randomized trials of breastâ conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am J Clin Oncol. 2005; 28: 289 â 294.
dc.identifier.citedreferenceKerrigan D, Waters P, Ryan M, et al. Followâ up arrangements for breast cancer patients; is it appropriate to transfer surveillance to general practitioners? Ir Med J. 2014; 107: 273 â 275.
dc.identifier.citedreferenceSaslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007; 57: 75 â 89.
dc.identifier.citedreferenceMoyer VA. Risk assessment, genetic counseling, and genetic testing for BRCAâ related cancer in women: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 160: 271 â 281.
dc.identifier.citedreferenceRock CL, Doyle C, Demarkâ Wahnefried W, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012; 62: 242 â 274.
dc.identifier.citedreferenceBrawley O, Byers T, Chen A, et al. New American Cancer Society process for creating trustworthy cancer screening guidelines. JAMA. 2011; 306: 2495 â 2499.
dc.identifier.citedreferenceBower JE, Bak K, Berger A, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol. 2014; 32: 1840 â 1850.
dc.identifier.citedreferenceHolland JC, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Distress Management Version 2.2015. © 2015 National Comprehensive Cancer Network, Inc. NCCN.org. Accessed April 1, 2015.
dc.identifier.citedreferenceLoren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013; 31: 2500 â 2510.
dc.identifier.citedreferenceThe University of Texas MD Anderson Cancer Center. Survivorshipâ Invasive Breast Cancer. mdanderson.org/educationâ andâ research/resourcesâ forâ professionals/clinicalâ toolsâ andâ resources/practiceâ algorithms/survivorshipâ breastâ invasiveâ webâ algorithm.pdf. Accessed April 7, 2014.
dc.identifier.citedreferenceHelfand M, Carson S. US Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Screening for Lipid Disorders in Adults: Selective Update of 2001 US Preventive Services Task Force Review. Rockville, MD: Agency for Healthcare Research and Quality; 2008.
dc.identifier.citedreferenceUS Preventive Services Task Force. Screening for osteoporosis: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2011; 154: 356 â 364.
dc.identifier.citedreferenceWatts NB, Bilezikian JP, Camacho PM, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2010; 16 ( suppl 3 ): 1 â 37.
dc.identifier.citedreferenceChalasani P, Downey L, Stopeck AT. Caring for the breast cancer survivor: a guide for primary care physicians. Am J Med. 2010; 123: 489 â 495.
dc.identifier.citedreferenceHarris SR, Schmitz KH, Campbell KL, McNeely ML. Clinical practice guidelines for breast cancer rehabilitation: syntheses of guideline recommendations and qualitative appraisals. Cancer. 2012; 118: 2312 â 2324.
dc.identifier.citedreferenceStout NL, Binkley JM, Schmitz KH, et al. A prospective surveillance model for rehabilitation for women with breast cancer. Cancer. 2012; 118: 2191 â 2200.
dc.identifier.citedreferencevan Londen G, Beckjord E, Dew M, Cuijpers P, Tadic S, Brufsky A. Breast cancer survivorship symptom management: current perspective and future development. Breast Cancer Manag. 2013; 2: 71 â 81.
dc.identifier.citedreferenceGanz PA, Yip CH, Gralow JR, et al. Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in lowâ and middleâ income countries. A Breast Health Global Initiative 2013 consensus statement. Breast. 2013; 22: 606 â 615.
dc.identifier.citedreferenceCenters for Disease Control and Prevention. Vaccines: VPDâ VAC/Who Should NOT Get Vaccinated? cdc.gov/vaccines/vpdâ vac/shouldâ notâ vacc.htm. Accessed August 17, 2015.
dc.identifier.citedreferenceRojas MP, Telaro E, Russo A, et al. Followâ up strategies for women treated for early breast cancer [serial online]. Cochrane Database Syst Rev. 2005;( 1 ): CD001768.
dc.identifier.citedreferenceSalani R, Andersen BL. Gynecologic care for breast cancer survivors: assisting in the transition to wellness. Am J Obstet Gynecol. 2012; 206: 390 â 397.
dc.identifier.citedreferenceDel Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V. Intensive diagnostic followâ up after treatment of primary breast cancer: a randomized trial. JAMA. 1994; 271: 1593 â 1597.
dc.identifier.citedreferenceImpact of followâ up testing on survival and healthâ related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators. JAMA. 1994; 271: 1587 â 1592.
dc.identifier.citedreferenceHenry LN, Hayes DF, Ramsey SD, Hortobagyi GN, Barlow WE, Gralow JR. Promoting quality and evidenceâ based care in earlyâ stage breast cancer followâ up [serial online]. J Natl Cancer Inst. 2014; 106: dju034.
dc.identifier.citedreferenceRuddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009; 59: 56 â 66.
dc.identifier.citedreferenceSmith RA, Manassaramâ Baptiste D, Brooks D, et al. Cancer screening in the United States, 2015: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2015; 65: 30 â 54.
dc.identifier.citedreferenceRunowicz CD. Gynecologic surveillance of women on tamoxifen: first do no harm. J Clin Oncol. 2000; 18: 3457 â 3458.
dc.identifier.citedreferenceFalk Dahl CA, Reinertsen KV, Nesvold IL, Fossa SD, Dahl AA. A study of body image in longâ term breast cancer survivors. Cancer. 2010; 116: 3549 â 3557.
dc.identifier.citedreferencePartridge AH. Cancer survivorship and the young breast cancer patient: addressing the important issues. Oncologist. 2013; 18: e19 â e20.
dc.identifier.citedreferenceAvis NE, Crawford S, Manuel J. Quality of life among younger women with breast cancer. J Clin Oncol. 2005; 23: 3322 â 3330.
dc.identifier.citedreferenceFobair P, Spiegel D. Concerns about sexuality after breast cancer. Cancer J. 2009; 15: 19 â 26.
dc.identifier.citedreferenceRosenberg SM, Tamimi RM, Gelber S, et al. Body image in recently diagnosed young women with early breast cancer. Psychooncology. 2013; 22: 1849 â 1855.
dc.identifier.citedreferenceDelanian S, Porcher R, Ballaâ Mekias S, Lefaix JL. Randomized, placeboâ controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiationâ induced fibrosis. J Clin Oncol. 2003; 21: 2545 â 2550.
dc.identifier.citedreferenceHaddad P, Kalaghchi B, Amouzegarâ Hashemi F. Pentoxifylline and vitamin E combination for superficial radiationâ induced fibrosis: a phase II clinical trial. Radiother Oncol. 2005; 77: 324 â 326.
dc.identifier.citedreferenceMagnusson M, Hoglund P, Johansson K, et al. Pentoxifylline and vitamin E treatment for prevention of radiationâ induced sideâ effects in women with breast cancer: a phase two, doubleâ blind, placeboâ controlled randomised clinical trial (Ptxâ 5). Eur J Cancer. 2009; 45: 2488 â 2495.
dc.identifier.citedreferenceOkunieff P, Augustine E, Hicks JE, et al. Pentoxifylline in the treatment of radiationâ induced fibrosis. J Clin Oncol. 2004; 22: 2207 â 2213.
dc.identifier.citedreferenceScott JL, Kayser K. A review of coupleâ based interventions for enhancing women’s sexual adjustment and body image after cancer. Cancer J. 2009; 15: 48 â 56.
dc.identifier.citedreferenceArmer JM. The problem of postâ breast cancer lymphedema: impact and measurement issues. Cancer Invest. 2005; 23: 76 â 83.
dc.identifier.citedreferenceArmer JM, Stewart BR. Postâ breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology. 2010; 43: 118 â 127.
dc.identifier.citedreferenceRadina ME, Armer JM, Stewart BR. Making selfâ care a priority for women at risk of breast cancerâ related lymphedema. J Fam Nurs. 2014; 20: 226 â 249.
dc.identifier.citedreferenceKrag DN, Anderson SJ, Julian TB, et al. Sentinelâ lymphâ node resection compared with conventional axillaryâ lymphâ node dissection in clinically nodeâ negative patients with breast cancer: overall survival findings from the NSABP Bâ 32 randomised phase 3 trial. Lancet Oncol. 2010; 11: 927 â 933.
dc.identifier.citedreferenceWarren LE, Miller CL, Horick N, et al. The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol Biol Phys. 2014; 88: 565 â 571.
dc.identifier.citedreferenceFu MR, Rosedale M. Breast cancer survivors’ experiences of lymphedemaâ related symptoms. J Pain Symptom Manage. 2009; 38: 849 â 859.
dc.identifier.citedreferenceInternational Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 consensus document of the international society of lymphology. Lymphology. 2013; 46: 1 â 11.
dc.identifier.citedreferenceShaitelman SF, Cromwell KD, Rasmussen JC, et al. Recent progress in the treatment and prevention of cancerâ related lymphedema. CA Cancer J Clin. 2015; 65: 55 â 81.
dc.identifier.citedreferenceOstby PL, Armer JM, Dale PS, Van Loo MJ, Wilbanks CL, Stewart BR. Surveillance recommendations in reducing risk of and optimally managing breast cancerâ related lymphedema. J Pers Med. 2014; 4: 424 â 447.
dc.identifier.citedreferenceCoriddi M, Khansa I, Stephens J, Miller M, Boehmler J, Tiwari P. Analysis of factors contributing to severity of breast cancerâ related lymphedema. Ann Plast Surg. 2015; 74: 22 â 25.
dc.identifier.citedreferenceSchmitz KH, Ahmed RL, Troxel AB, et al. Weight lifting for women at risk for breast cancerâ related lymphedema: a randomized trial. JAMA. 2010; 304: 2699 â 2705.
dc.identifier.citedreferenceCemal Y, Pusic A, Mehrara BJ. Preventative measures for lymphedema: separating fact from fiction. J Am Coll Surg. 2011; 213: 543 â 551.
dc.identifier.citedreferenceAhmed RL, Thomas W, Yee D, Schmitz KH. Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol. 2006; 24: 2765 â 2772.
dc.identifier.citedreferenceDominick SA, Natarajan L, Pierce JP, Madanat H, Madlensky L. Patient compliance with a health care provider referral for an occupational therapy lymphedema consult. Support Care Cancer. 2014; 22: 1781 â 1787.
dc.identifier.citedreferenceDarby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013; 368: 987 â 998.
dc.identifier.citedreferenceBarton M. Cholesterol and atherosclerosis: modulation by oestrogen. Curr Opin Lipidol. 2013; 24: 214 â 220.
dc.identifier.citedreferenceChalasani P, Livingston R. Differential chemotherapeutic sensitivity for breast tumors with â BRCAnessâ : a review. Oncologist. 2013; 18: 909 â 916.
dc.identifier.citedreferenceCurigliano G, Cardinale D, Suter T, et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol. 2012; 23: vii155 â vii166.
dc.identifier.citedreferenceBell LN, Nguyen AT, Li L, et al. Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole. J Clin Pharmacol. 2012; 52: 1852 â 1860.
dc.identifier.citedreferenceMouridsen H, Giobbieâ Hurder A, Goldhirsch A, et al. Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. N Engl J Med. 2009; 361: 766 â 776.
dc.identifier.citedreferenceStan D, Loprinzi CL, Ruddy KJ. Breast cancer survivorship issues. Hematol Oncol Clin North Am. 2013; 27: 805 â 827, ix.
dc.identifier.citedreferenceVon Ah D, Habermann B, Carpenter JS, Schneider BL. Impact of perceived cognitive impairment in breast cancer survivors. Eur J Oncol Nurs. 2013; 17: 236 â 241.
dc.identifier.citedreferenceJanelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR. An update on cancerâ and chemotherapyâ related cognitive dysfunction: current status. Semin Oncol. 2011; 38: 431 â 438.
dc.identifier.citedreferenceReidâ Arndt SA, Yee A, Perry MC, Hsieh C. Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors. J Psychosoc Oncol. 2009; 27: 415 â 434.
dc.identifier.citedreferenceReuterâ Lorenz P, Cimprich B. Cognitive function and breast cancer: promise and potential insights from functional brain imaging. Breast Cancer Res Treat. 2013; 137: 33 â 43.
dc.identifier.citedreferenceBruno J, Hosseini SM, Kesler S. Altered resting state functional brain network topology in chemotherapyâ treated breast cancer survivors. Neurobiol Dis. 2012; 48: 329 â 338.
dc.identifier.citedreferenceDumas JA, Makarewicz J, Schaubhut GJ, et al. Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study. Brain Imaging Behav. 2013; 7: 524 â 532.
dc.identifier.citedreferenceFalleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a metaâ analysis of the current literature. Brain Cogn. 2005; 59: 60 â 70.
dc.identifier.citedreferenceHurria A, Lachs M. Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer? Breast Cancer Res Treat. 2007; 103: 259 â 268.
dc.identifier.citedreferenceGanz PA, Petersen L, Castellon SA, et al. Cognitive function after the initiation of adjuvant endocrine therapy in earlyâ stage breast cancer: an observational cohort study. J Clin Oncol. 2014; 32: 3559 â 3567.
dc.identifier.citedreferenceAhles TA, Saykin AJ, McDonald BC, et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol. 2010; 28: 4434 â 4440.
dc.identifier.citedreferenceAhles TA, Saykin AJ. Breast cancer chemotherapyâ related cognitive dysfunction. Clin Breast Cancer. 2002; 3 ( suppl 3 ): S84 â S90.
dc.identifier.citedreferenceSmall BJ, Rawson KS, Walsh E, et al. Catecholâ Oâ methyltransferase genotype modulates cancer treatmentâ related cognitive deficits in breast cancer survivors. Cancer. 2011; 117: 1369 â 1376.
dc.identifier.citedreferenceKohli S, Fisher SG, Tra Y, et al. The effect of modafinil on cognitive function in breast cancer survivors. Cancer. 2009; 115: 2605 â 2616.
dc.identifier.citedreferenceVon Ah D, Jansen C, Allen DH, Schiavone RM, Wulff J. Putting evidence into practice: evidenceâ based interventions for cancer and cancer treatmentâ related cognitive impairment. Clin J Oncol Nurs. 2011; 15: 607 â 615.
dc.identifier.citedreferenceVon Ah D, Carpenter JS, Saykin A, et al. Advanced cognitive training for breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat. 2012; 135: 799 â 809.
dc.identifier.citedreferenceErcoli LM, Petersen L, Hunter AM, et al. Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial [published online ahead of print March 10, 2015 ]. Psychooncology. doi: 10.1002/pon.3769.
dc.identifier.citedreferenceSiegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 104 â 117.
dc.identifier.citedreferenceSimard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013; 7: 300 â 322.
dc.identifier.citedreferenceBoyes AW, Girgis A, Zucca AC, Lecathelinais C. Anxiety and depression among longâ term survivors of cancer in Australia: results of a populationâ based survey [comment]. Med J Aust. 2009; 191: 295.
dc.identifier.citedreferenceHoffman KE, McCarthy EP, Recklitis CJ, Ng AK. Psychological distress in longâ term survivors of adultâ onset cancer: results from a national survey. Arch Intern Med. 2009; 169: 1274 â 1281.
dc.identifier.citedreferenceMcGinty HL, Goldenberg JL, Jacobsen PB. Relationship of threat appraisal with coping appraisal to fear of cancer recurrence in breast cancer survivors. Psychooncology. 2012; 21: 203 â 210.
dc.identifier.citedreferenceMitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P. Depression and anxiety in longâ term cancer survivors compared with spouses and healthy controls: a systematic review and metaâ analysis. Lancet Oncol. 2013; 14: 721 â 732.
dc.identifier.citedreferenceZainal NZ, Nikâ Jaafar NR, Baharudin A, Sabki ZA, Ng CG. Prevalence of depression in breast cancer survivors: a systematic review of observational studies. Asian Pac J Cancer Prev. 2013; 14: 2649 â 2656.
dc.identifier.citedreferenceVan Poznak C. Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition [serial online]. Breast Cancer Res. 2010; 12: 110.
dc.identifier.citedreferencePatel D, Sharpe L, Thewes B, Bell ML, Clarke S. Using the Distress Thermometer and Hospital Anxiety and Depression Scale to screen for psychosocial morbidity in patients diagnosed with colorectal cancer. J Affect Disord. 2011; 131: 412 â 416.
dc.identifier.citedreferenceKroenke K, Spitzer RL, Williams JB. The PHQâ 9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606 â 613.
dc.identifier.citedreferenceSpitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GADâ 7. Arch Intern Med. 2006; 166: 1092 â 1097.
dc.identifier.citedreferenceEwertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol. 2011; 50: 187 â 193.
dc.identifier.citedreferenceHa EH, Cho YK. The mediating effects of selfâ esteem and optimism on the relationship between quality of life and depressive symptoms of breast cancer patients. Psychiatry Investig. 2014; 11: 437 â 445.
dc.identifier.citedreferenceRosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol. 1999; 19: 67 â 85.
dc.identifier.citedreferenceSpeer JJ, Hillenberg B, Sugrue DP, et al. Study of sexual functioning determinants in breast cancer survivors. Breast J. 2005; 11: 440 â 447.
dc.identifier.citedreferenceCasellasâ Grau A, Font A, Vives J. Positive psychology interventions in breast cancer. A systematic review. Psychooncology. 2014; 23: 9 â 19.
dc.identifier.citedreferenceBower JE. Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol. 2008; 26: 768 â 777.
dc.identifier.citedreferenceJacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GH. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage. 1999; 18: 233 â 242.
dc.identifier.citedreferenceGastonâ Johansson F, Fallâ Dickson JM, Bakos AB, Kennedy MJ. Fatigue, pain, and depression in preâ autotransplant breast cancer patients. Cancer Pract. 1999; 7: 240 â 247.
dc.identifier.citedreferenceMenesesâ Echavez JF, Gonzalezâ Jimenez E, Ramirezâ Velez R. Effects of supervised exercise on cancerâ related fatigue in breast cancer survivors: a systematic review and metaâ analysis [serial online]. BMC Cancer. 2015; 15: 77.
dc.identifier.citedreferenceGielissen MF, Verhagen CA, Bleijenberg G. Cognitive behaviour therapy for fatigued cancer survivors: longâ term followâ up. Br J Cancer. 2007; 97: 612 â 618.
dc.identifier.citedreferenceDuijts SF, Faber MM, Oldenburg HS, van Beurden M, Aaronson NK. Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and healthâ related quality of life in breast cancer patients and survivorsâ a metaâ analysis. Psychooncology. 2011; 20: 115 â 126.
dc.identifier.citedreferenceKanis JA, McCloskey EV, Powles T, Paterson AH, Ashley S, Spector T. A high incidence of vertebral fracture in women with breast cancer. Br J Cancer. 1999; 79: 1179 â 1181.
dc.identifier.citedreferenceChen Z, Maricic M, Bassford TL, et al. Fracture risk among breast cancer survivors: results from the Women’s Health Initiative Observational Study. Arch Intern Med. 2005; 165: 552 â 558.
dc.identifier.citedreferenceChen Z, Maricic M, Pettinger M, et al. Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer. Cancer. 2005; 104: 1520 â 1530.
dc.identifier.citedreferenceLindsey AM, Gross G, Twiss J, Waltman N, Ott C, Moore TE. Postmenopausal survivors of breast cancer at risk for osteoporosis: nutritional intake and body size. Cancer Nurs. 2002; 25: 50 â 56.
dc.identifier.citedreferenceGralow JR, Biermann JS, Farooki A, et al. NCCN Task Force Report: Bone Health in Cancer Care. J Natl Compr Canc Netw. 2013; 11 ( suppl 3 ): S1 â S50; quiz S51.
dc.identifier.citedreferenceJohnell O, Kanis JA, Oden A, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005; 20: 1185 â 1194.
dc.identifier.citedreferenceKanis JA, Borgstrom F, De Laet C, et al. Assessment of fracture risk. Osteoporos Int. 2005; 16: 581 â 589.
dc.identifier.citedreferenceFeskanich D, Willett W, Colditz G. Walking and leisureâ time activity and risk of hip fracture in postmenopausal women. JAMA. 2002; 288: 2300 â 2306.
dc.identifier.citedreferenceMoyer VA. Prevention of falls in communityâ dwelling older adults: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2012; 157: 197 â 204.
dc.identifier.citedreferenceCosman F, de Beur SJ, LeBoff MS, et al. Clinican’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25: 2359 â 2381.
dc.identifier.citedreferenceChapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992; 327: 1637 â 1642.
dc.identifier.citedreferenceDawsonâ Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997; 337: 670 â 676.
dc.identifier.citedreferenceMurad MH, Elamin KB, Abu Elnour NO, et al. Clinical review: the effect of vitamin D on falls: a systematic review and metaâ analysis. J Clin Endocrinol Metab. 2011; 96: 2997 â 3006.
dc.identifier.citedreferenceGreenspan SL, Nelson JB, Trump DL, Resnick NM. Effect of onceâ weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial. Ann Intern Med. 2007; 146: 416 â 424.
dc.identifier.citedreferenceVan Poznak C, Hannon RA, Mackey JR, et al. Prevention of aromatase inhibitorâ induced bone loss using risedronate: the SABRE trial. J Clin Oncol. 2010; 28: 967 â 975.
dc.identifier.citedreferenceBaum M, Budzar AU, Cuzick J, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet. 2002; 359: 2131 â 2139.
dc.identifier.citedreferenceStubblefield MD, Keole N. Upper body pain and functional disorders in patients with breast cancer. PM R. 2014; 6: 170 â 183.
dc.identifier.citedreferenceHarrington S, Padua D, Battaglini C, et al. Comparison of shoulder flexibility, strength, and function between breast cancer survivors and healthy participants. J Cancer Surviv. 2011; 5: 167 â 174.
dc.identifier.citedreferenceFenlon D, Addingtonâ Hall JM, O’Callaghan AC, Clough J, Nicholls P, Simmonds P. A survey of joint and muscle aches, pain, and stiffness comparing women with and without breast cancer. J Pain Symptom Manage. 2013; 46: 523 â 535.
dc.identifier.citedreferenceKarki A, Simonen R, Malkia E, Selfe J. Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. J Rehabil Med. 2005; 37: 180 â 188.
dc.identifier.citedreferenceKakuda JT, Stuntz M, Trivedi V, Klein SR, Vargas HI. Objective assessment of axillary morbidity in breast cancer treatment. Am Surg. 1999; 65: 995 â 998.
dc.identifier.citedreferenceKuehn T, Klauss W, Darsow M, et al. Longâ term morbidity following axillary dissection in breast cancer patientsâ clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat. 2000; 64: 275 â 286.
dc.identifier.citedreferenceCrew KD, Greenlee H, Capodice J, et al. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for earlyâ stage breast cancer. J Clin Oncol. 2007; 25: 3877 â 3883.
dc.identifier.citedreferenceHenry NL, Azzouz F, Desta Z, et al. Predictors of aromatase inhibitor discontinuation as a result of treatmentâ emergent symptoms in earlyâ stage breast cancer. J Clin Oncol. 2012; 30: 936 â 942.
dc.identifier.citedreferenceHershman DL, Kushi LH, Shao T, et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 earlyâ stage breast cancer patients. J Clin Oncol. 2010; 28: 4120 â 4128.
dc.identifier.citedreferenceBarron TI, Cahir C, Sharp L, Bennett K. A nested caseâ control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage Iâ III breast cancer. Br J Cancer. 2013; 109: 1513 â 1521.
dc.identifier.citedreferenceDe Groef A, Van Kampen M, Dieltjens E, et al. Effectiveness of postoperative physical therapy for upperâ limb impairments after breast cancer treatment: a systematic review. Arch Phys Med Rehabil. 2015; 96: 1140 â 1153.
dc.identifier.citedreferenceLoh SY, Musa AN. Methods to improve rehabilitation of patients following breast cancer surgery: a review of systematic reviews. Breast Cancer (Dove Med Press). 2015; 7: 81 â 98.
dc.identifier.citedreferenceIrwin ML, Cartmel B, Gross CP, et al. Randomized exercise trial of aromatase inhibitorâ induced arthralgia in breast cancer survivors. J Clin Oncol. 2015; 33: 1104 â 1111.
dc.identifier.citedreferenceCrew KD, Capodice JL, Greenlee H, et al. Randomized, blinded, shamâ controlled trial of acupuncture for the management of aromatase inhibitorâ associated joint symptoms in women with earlyâ stage breast cancer. J Clin Oncol. 2010; 28: 1154 â 1160.
dc.identifier.citedreferenceAndersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. 2011; 12: 725 â 746.
dc.identifier.citedreferenceGartner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009; 302: 1985 â 1992.
dc.identifier.citedreferencePachman DR, Barton DL, Watson JC, Loprinzi CL. Chemotherapyâ induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther. 2011; 90: 377 â 387.
dc.identifier.citedreferenceSteegers MA, Snik DM, Verhagen AF, van der Drift MA, Wilderâ Smith OH. Only half of the chronic pain after thoracic surgery shows a neuropathic component. J Pain. 2008; 9: 955 â 961.
dc.identifier.citedreferenceGarcia MK, McQuade J, Haddad R, et al. Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol. 2013; 31: 952 â 960.
dc.identifier.citedreferenceMishra SI, Scherer RW, Geigle PM, et al. Exercise interventions on healthâ related quality of life for cancer survivors [serial online]. Cochrane Database Syst Rev. 2012;( 8 ): CD007566.
dc.identifier.citedreferenceCourneya KS, McKenzie DC, Mackey JR, et al. Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy. Br J Cancer. 2014; 111: 1718 â 1725.
dc.identifier.citedreferenceSmith E, Pang H, Cirrincione C, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapyâ induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013; 309: 1359 â 1367.
dc.identifier.citedreferenceKort JD, Eisenberg ML, Millheiser LS, Westphal LM. Fertility issues in cancer survivorship. CA Cancer J Clin. 2014; 64: 118 â 134.
dc.identifier.citedreferenceGanz PA, Land SR, Geyer CE Jr, et al. Menstrual history and qualityâ ofâ life outcomes in women with nodeâ positive breast cancer treated with adjuvant therapy on the NSABP Bâ 30 trial. J Clin Oncol. 2011; 29: 1110 â 1116.
dc.identifier.citedreferenceRosen MP, Sternfeld B, Schuhâ Huerta SM, Reijo Pera RA, McCulloch CE, Cedars MI. Antral follicle count: absence of significant midlife decline. Fertil Steril. 2010; 94: 2182 â 2185.
dc.identifier.citedreferenceSadovsky R, Basson R, Krychman M, et al. Cancer and sexual problems. J Sex Med. 2010; 7: 349 â 373.
dc.identifier.citedreferenceBerkey FJ. Managing the adverse effects of radiation therapy. Am Fam Physician. 2010; 82: 381 â 388, 394.
dc.identifier.citedreferenceMazzarello S, Hutton B, Ibrahim MF, et al. Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials. Breast Cancer Res Treat. 2015; 152: 1 â 8.
dc.identifier.citedreferencePruthi S, Simon JA, Early AP. Current overview of the management of urogenital atrophy in women with breast cancer. Breast J. 2011; 17: 403 â 408.
dc.identifier.citedreferenceKendall A, Dowsett M, Folkerd E, Smith I. Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol. 2006; 17: 584 â 587.
dc.identifier.citedreferenceRowland JH, Meyerowitz BE, Crespi CM, et al. Addressing intimacy and partner communication after breast cancer: a randomized controlled group intervention. Breast Cancer Res Treat. 2009; 118: 99 â 111.
dc.identifier.citedreferenceMurthy V, Chamberlain RS. Menopausal symptoms in young survivors of breast cancer: a growing problem without an ideal solution. Cancer Control. 2012; 19: 317 â 329.
dc.identifier.citedreferenceKaplan M, Mahon S, Cope D, Keating E, Hill S, Jacobson M. Putting evidence into practice: evidenceâ based interventions for hot flashes resulting from cancer therapies. Clin J Oncol Nurs. 2011; 15: 149 â 157.
dc.identifier.citedreferenceJin Y, Desta Z, Stearns V, et al. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst. 2005; 97: 30 â 39.
dc.identifier.citedreferenceBurstein HJ, Prestrud AA, Seidenfeld J, et al. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptorâ positive breast cancer. J Clin Oncol. 2010; 28: 3784 â 3796.
dc.identifier.citedreferenceLoprinzi CL, Sloan J, Stearns V, et al. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol. 2009; 27: 2831 â 2837.
dc.identifier.citedreferenceBordeleau L, Pritchard KI, Loprinzi CL, et al. Multicenter, randomized, crossâ over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J Clin Oncol. 2010; 28: 5147 â 5152.
dc.identifier.citedreferencePandya KJ, Morrow GR, Roscoe JA, et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised doubleâ blind placeboâ controlled trial. Lancet. 2005; 366: 818 â 824.
dc.identifier.citedreferenceClayden JR, Bell JW, Pollard P. Menopausal flushing: doubleâ blind trial of a nonâ hormonal medication. BMJ. 1974; 1: 409 â 412.
dc.identifier.citedreferenceChiu HY, Shyu YK, Chang PC, Tsai PS. Effects of acupuncture on menopauseâ related symptoms in breast cancer survivors: a metaâ analysis of randomized controlled trials [published online ahead of print June 3, 2015 ]. Cancer Nurs. doi: 10.1097/NCC.0000000000000278.
dc.identifier.citedreferenceBordeleau L, Pritchard K, Goodwin P, Loprinzi C. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidenceâ based review. Clin Ther. 2007; 29: 230 â 241.
dc.identifier.citedreferenceChan DS, Vieira AR, Aune D, et al. Body mass index and survival in women with breast cancerâ systematic literature review and metaâ analysis of 82 followâ up studies. Ann Oncol. 2014; 25: 1901 â 1914.
dc.identifier.citedreferenceMcTiernan A, Irwin M, Vongruenigen V. Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol. 2010; 28: 4074 â 4080.
dc.identifier.citedreferenceWei EK, Wolin KY, Colditz GA. Time course of risk factors in cancer etiology and progression. J Clin Oncol. 2010; 28: 4052 â 4057.
dc.identifier.citedreferencePatterson RE, Cadmus LA, Emond JA, Pierce JP. Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas. 2010; 66: 5 â 15.
dc.identifier.citedreferenceKellen E, Vansant G, Christiaens MR, Neven P, Van Limbergen E. Lifestyle changes and breast cancer prognosis: a review. Breast Cancer Res Treat. 2009; 114: 13 â 22.
dc.identifier.citedreferenceFriedenreich CM. Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms. Recent Results Cancer Res. 2011; 188: 125 â 139.
dc.identifier.citedreferenceBarbaric M, Brooks E, Moore L, Cheifetz O. Effects of physical activity on cancer survival: a systematic review. Physiother Can. 2010; 62: 25 â 34.
dc.identifier.citedreferenceCarmichael AR, Daley AJ, Rea DW, Bowden SJ. Physical activity and breast cancer outcome: a brief review of evidence, current practice and future direction. Eur J Surg Oncol. 2010; 36: 1139 â 1148.
dc.identifier.citedreferenceSpeedâ Andrews AE, Courneya KS. Effects of exercise on quality of life and prognosis in cancer survivors. Curr Sports Med Rep. 2009; 8: 176 â 181.
dc.identifier.citedreferenceIrwin ML, Mayne ST. Impact of nutrition and exercise on cancer survival. Cancer J. 2008; 14: 435 â 441.
dc.identifier.citedreferenceLahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and metaâ analysis of epidemiological studies. Acta Oncol. 2015; 54: 635 â 654.
dc.identifier.citedreferenceBallardâ Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, Alfano CM. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst. 2012; 104: 815 â 840.
dc.identifier.citedreferenceBinkley JM, Harris SR, Levangie PK, et al. Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer. Cancer. 2012; 118: 2207 â 2216.
dc.identifier.citedreferenceCappiello M, Cunningham RS, Knobf MT, Erdos D. Breast cancer survivors: information and support after treatment. Clin Nurs Res. 2007; 16: 278 â 293; discussion 294â 301.
dc.identifier.citedreferenceBloom JR, Stewart SL, Chang S, Banks PJ. Then and now: quality of life of young breast cancer survivors. Psychooncology. 2004; 13: 147 â 160.
dc.identifier.citedreferenceBlank TO, Bellizzi KM. A gerontologic perspective on cancer and aging. Cancer. 2008; 112: 2569 â 2576.
dc.identifier.citedreferenceHowardâ Anderson J, Ganz PA, Bower JE, Stanton AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst. 2012; 104: 386 â 405.
dc.identifier.citedreferenceStricker CT, Jacobs LA, Risendal B, et al. Survivorship care planning after the Institute of Medicine recommendations: how are we faring? J Cancer Surviv. 2011; 5: 358 â 370.
dc.identifier.citedreferenceBrennan ME, Gormally JF, Butow P, Boyle FM, Spillane AJ. Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer. 2014; 111: 1899 â 1908.
dc.identifier.citedreferenceMayer DK, Birken SA, Check DK, Chen RC. Summing it up: an integrative review of studies of cancer survivorship care plans (2006â 2013). Cancer. 2015; 121: 978 â 996.
dc.identifier.citedreferenceGrunfeld E, Julian JA, Pond G, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol. 2011; 29: 4755 â 4762.
dc.identifier.citedreferenceBrothers BM, Easley A, Salani R, Andersen BL. Do survivorship care plans impact patients’ evaluations of care? A randomized evaluation with gynecologic oncology patients. Gynecol Oncol. 2013; 129: 554 â 558.
dc.identifier.citedreferenceHershman DL, Greenlee H, Awad D, et al. Randomized controlled trial of a clinicâ based survivorship intervention following adjuvant therapy in breast cancer survivors. Breast Cancer Res Treat. 2013; 138: 795 â 806.
dc.identifier.citedreferenceEzendam NP, Nicolaije KA, Kruitwagen RF, et al. Survivorship Care Plans to inform the primary care physician: results from the ROGY care pragmatic cluster randomized controlled trial. J Cancer Surviv. 2014; 8: 595 â 602.
dc.identifier.citedreferenceIrwin ML, McTiernan A, Bernstein L, et al. Physical activity levels among breast cancer survivors. Med Sci Sports Exerc. 2004; 36: 1484 â 1491.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
caac21319_am.pdf
Size:
1.581MB
Format:
PDF
View/Open
Name:
caac21319-sup-0001-suppinfo1.pdf
Size:
677.9KB
Format:
PDF
View/Open
Name:
caac21319.pdf
Size:
618.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.